Los Angeles Capital Management LLC Alkermes Plc. Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 136,697 shares of ALKS stock, worth $4.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

136,697

Previous 137,302 0.44%

Holding current value

$4.26 Million

Previous $3.31 Million 15.66%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$23.01 - $28.55 $13,921 - $17,272	-605 Reduced 0.44%	136,697 $3.83 Million
Q2 2024 Aug 05, 2024	SELL	$23.21 - $27.24 $210,723 - $247,311	-9,079 Reduced 6.2%	137,302 $3.31 Million
Q1 2024 Apr 05, 2024	BUY	$26.4 - $32.56 $3.25 Million - $4 Million	122,980 Added 525.53%	146,381 $3.96 Million
Q4 2023 Feb 06, 2024	BUY	$23.37 - $28.68 $103,295 - $126,765	4,420 Added 23.29%	23,401 $649,000
Q3 2023 Nov 06, 2023	BUY	$27.17 - $31.97 $282,187 - $332,040	10,386 Added 120.84%	18,981 $531,000
Q2 2023 Aug 03, 2023	BUY	$28.34 - $33.63 $243,582 - $289,049	8,595 New	8,595 $269,000
Q4 2022 Feb 06, 2023	SELL	$21.94 - $26.24 $100,924 - $120,704	-4,600 Reduced 5.92%	73,096 $1.91 Million
Q3 2022 Nov 02, 2022	BUY	$22.0 - $31.87 $1.38 Million - $2 Million	62,695 Added 417.94%	77,696 $1.74 Million
Q2 2022 Aug 05, 2022	BUY	$26.4 - $30.54 $396,026 - $458,130	15,001 New	15,001 $447,000
Q3 2020 Nov 02, 2020	SELL	$16.16 - $20.66 $178,891 - $228,706	-11,070 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$13.31 - $19.41 $332,616 - $485,055	-24,990 Reduced 69.3%	11,070 $214,000
Q1 2020 May 04, 2020	SELL	$13.06 - $21.24 $640,462 - $1.04 Million	-49,040 Reduced 57.63%	36,060 $520,000
Q4 2019 Feb 07, 2020	BUY	$17.29 - $21.74 $1.47 Million - $1.85 Million	85,100 New	85,100 $1.74 Million
Q3 2019 Nov 07, 2019	SELL	$19.51 - $24.28 $721,089 - $897,388	-36,960 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$21.47 - $37.33 $5.09 Million - $8.85 Million	-237,022 Reduced 86.51%	36,960 $833,000
Q1 2019 Apr 25, 2019	BUY	$28.4 - $36.49 $5.31 Million - $6.82 Million	186,840 Added 214.41%	273,982 $10 Million
Q4 2018 Feb 11, 2019	SELL	$27.94 - $44.61 $1.7 Million - $2.71 Million	-60,747 Reduced 41.08%	87,142 $2.57 Million
Q3 2018 Nov 05, 2018	BUY	$38.6 - $46.12 $2.52 Million - $3.01 Million	65,330 Added 79.13%	147,889 $6.28 Million
Q2 2018 Jul 31, 2018	BUY	$40.56 - $51.36 $3.35 Million - $4.24 Million	82,559 New	82,559 $3.4 Million
Q4 2017 Feb 05, 2018	SELL	$47.69 - $55.39 $12.5 Million - $14.5 Million	-261,977 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$49.16 - $54.45 $8.67 Million - $9.61 Million	176,442 Added 206.28%	261,977 $13.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	85,535	85,535 $4.96 Million

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

180M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.12B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Alkermes Plc. Transaction History